- The 8th International Congress on Lipid & Atherosclerosis (ICoLA)
-
The 58th Fall Conference of the Korean Society of Lipid & Atherosclerosis
September 5 (Thu) ~ 7 (Sat), 2019
Conrad Seoul Hotel, Korea
- Key Speakers
-
-
Stefano Del Prato, M.D.
(University of Pisa, Italy)
The Benefits of GLP 1-RA and SGLT2 Inhibitor for the CV Outcomes: What is Similar or Different?
Ira J. Goldberg, M.D.
(New York University, USA)
My Sweet Heart Was Broken: Fat Metabolism and Diabetes in the Heart
-
Kenneth Walsh, Ph.D.
(University of Virginia, USA)
Killer Clones: Clonal Hematopoiesis as a New Causal Risk Factor for Cardiovascular Disease
Gregory G. Schwartz, M.D., Ph.D.
(University of Colorado, USA)
Metformin: Is it a Cardiovascular Drug?
-
Laurent Yvan-Charvet, Ph.D.
(Institut national de la sante et de la recherche medicale, France)
Metabolic Reprogramming of Macrophage in Atherosclerosis: Is it All about Cholesterol?
Sripal Bangalore, M.D.
(New York University, USA)
Cardiovascular Risk Factors - It's Time to Focus on Variability
-
- Deadlines
-
- Late-breaking Abstract Submission June 19 (Wed.), 2019 closed
- Notification of AcceptanceJuly 05 (Fri.), 2019
- Pre-registrationAugust 16 (Fri.), 2019 closed
- News & Notice
-
- Warmest congratulations on your achievement 2019.09.11
- [Event] Free Starbucks coffee with app download 2019.08.29
- [Newsletter Vol.21] Welcome! See you in ICoLA 2019, Seoul soon! 2019.08.29
- [Newsletter Vol.20] Last chance to register with reduced registration fee. 2019.08.23
- [Newsletter Vol. 19] Pre-registration D-1! Here is your one and only chance! 2019.08.23
-
IVBM 2020
-
Sep. 9~12, 2020
Conrad Hotal, Seoul, Korea
